Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
Date:2/24/2011

THE WOODLANDS, Texas, Feb. 24, 2011 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2010.  

"We achieved significant progress in the advancement of our drug pipeline in 2010, led by positive results in clinical trials of LX4211 for type 2 diabetes," said Dr. Arthur T. Sands, president and chief executive officer of Lexicon. "We also reported the results of a Phase 2a trial of LX2931 in rheumatoid arthritis, demonstrating a preliminary signal of efficacy and favorable safety profile that we believe supports exploration of higher doses in future studies."

Key Developments of 2010

  • Lexicon reported positive results from a Phase 2a clinical trial of LX4211, a dual inhibitor of sodium-glucose cotransporters 1 and 2, showing statistically significant and rapid improvements in multiple parameters in patients with type 2 diabetes, including significant reductions of HbA1c within four weeks.  Lexicon also reported positive results from a mechanistic study of a tablet formulation of LX4211, showing significantly increased levels of GLP-1 and PYY, important mediators of glycemic and appetite control.  Lexicon plans to initiate a Phase 2b study of LX4211 around mid-year 2011.
  • Lexicon continued its efforts to develop an improved formulation of LX1031, an inhibitor of tryptophan hydro
    '/>"/>

    • SOURCE Lexicon Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011
    2. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
    3. Lexicon Pharmaceuticals to Present at the 29th Annual JPMorgan Healthcare Conference
    4. Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis
    5. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
    6. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
    7. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results
    8. Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs
    9. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
    10. Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
    11. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/17/2013)... Actavis, Inc. (NYSE: ACT ) today ... decision of the U.S. Court of Appeals for the Eleventh ... motion to dismiss the Federal Trade Commission,s lawsuit, FTC ... result of a decision by a 5 to 3 vote.  ... adopted the traditional "rule of reason" as the standard.  ...
    (Date:6/17/2013)... TEL AVIV, Israel , June 17, 2013 /PRNewswire/ ... 2013, the Board of Governors of the Israel-U.S. Binational ... $10.95 million in funding for fourteen new projects between ... from BIRD , the projects will access private ... to approximately $33 million. The semi-annual meeting was held ...
    (Date:6/17/2013)... NEW ORLEANS , June 17, 2013 /PRNewswire/ ... for new technologies that will help improve medication ... process across its health system. ... a combination of hardware and software that helps ... to dispense and administer medications because of simpler, ...
    Breaking Medicine Technology:U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 2Ochsner Health System Improves Safety Through Advanced Medication Management Technology 3Ochsner Health System Improves Safety Through Advanced Medication Management Technology 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 5
    ... 23 Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") ... extraordinary dividend of $0.18 per share of common stock, which ... record as of November 30, 2009. The December 9, 2009 ... pursuant to a plan of complete liquidation and dissolution and ...
    ... Calif., Nov. 23 Advanced Sterilization Products (ASP), ... today the acquisition by its French affiliate, Apsis ... of innovative disinfection processes and technologies to prevent ... disclosed. , Gloster Europe designs and markets ...
    Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2
    (Date:6/17/2013)... The distribution of white matter brain ... (MTBI) closely resembles that found in early Alzheimer’s dementia, ... journal Radiology. , “Findings of MTBI bear a ... said the study’s lead author, Saeed Fakhran, M.D., assistant ... the University of Pittsburgh School of Medicine. “Additional research ...
    (Date:6/17/2013)... 18, 2013 Essential tremor (ET) is ... estimated 10 million people in the United States, and ... clear understanding what causes ET, there are no medications ... cure. Tulips for Tremor© is the International Essential Tremor ... of and a cure for this life-altering neurological condition. ...
    (Date:6/17/2013)... BROOK, Ill. The distribution of white matter brain ... (MTBI) closely resembles that found in early Alzheimer,s dementia, ... journal Radiology . , "Findings of MTBI ... Alzheimer,s dementia," said the study,s lead author, Saeed Fakhran, ... Neuroradiology at the University of Pittsburgh School of Medicine. ...
    (Date:6/17/2013)... Daimer Industries, Inc.®, a well-renowned U.S. based ... as expertly designed carpet steam cleaner and vapor steam ... for apartment dwellers and homeowners. The commercial steam cleaner ... and pressure levels up to 75 psi to clean ... to clean carpet spots and areas in homes, but ...
    (Date:6/17/2013)... (PRWEB) June 17, 2013 Nearly 26 ... as many as 79 million adults are estimated to ... to prevent type 2 diabetes through weight loss and ... can help bring your blood sugar level back within ... and factors, 101 Medical Weight Loss physicians can help ...
    Breaking Medicine News(10 mins):Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4
    ... heart surgery fare better if they receive reconstituted blood ... ,Investigators say that children who received reconstituted blood -- ... plasma -- tended to accumulate less fluid, which leads ... researchers compared results for 200 infants who underwent heart ...
    ... research shows consuming large quantities of alcohol may increase ... ,Researchers studied more than 47,000 men and women. Participants ... and what type of alcohol they consumed. It was ... grams of alcohol each day, while the women consumed ...
    ... treating benign tumors outside the brain using the CyberKnife ... progression with minimal toxicity. CyberKnife is a non-invasive robotic ... without open surgery. It uses a robotic arm, controlled ... radiation directly to the tumor site. ,During ...
    ... shows that a common class of drugs used for acute ... to treat.// ,Researchers studied the use of bronchodilators known ... relieve acute asthma attacks. The drugs come in many forms ... pill or liquid form, delivered in a nebulizer, or given ...
    ... when they are diagnosed with early-stage breast cancer are at ... normal weight.// ,Studies in the past have shown that ... has also shown to have contradictory results about the influence ... researchers say, they have demonstrated a significant association between obesity ...
    ... known to cause cognitive and behavioral changes in diabetics, ... blood sugar // has a similar effect. ... cognitive functioning and experience deterioration in mood when their ... blood sugar levels due to insulin deficiencies. Patients often ...
    Cached Medicine News:
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: